Keywords: celltech, reflects, pipeline, after, mixed, fortunes, uk

Celltech Reflects On Pipeline After Mixed Fortunes In '97

Article | 16 December 1997

Print This

Celltech of the UK, which has described 1997 as an "annus horribilis"(Marketletter December 15) following the failure of its antibody for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in